Furthermore, HSP90 expression is found enriched in other therapy refractory leukemia subtypes, including acute or chronic myeloid leukemia (AML or CML) [10–13] and BCR-ABL1-like BCP-ALL [14, 15]. Here, HSP90AA1 is linked to leukemia.